Company / Profit Margin
NewAmsterdam Pharma Co N.V. Profit Margin History
FY2022-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-22.0%
FY2022
5-year range
-22.0% / -22.0%
FY2022-FY2022
Trend
-
vs FY2021
Sector context
#71 of 107
Health Care
What the data says
At -22.0%, NewAmsterdam Pharma Co N.V.'s profit margin ranks #71 of 107 in the Health Care sector.
Based on SEC 10-K filings.
-22.0% in FY2022.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#71 of 107 in Health CareTop 66% of 107This company -22.0% Sector average -48.0%
▼
+54.1% above sector average
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.01 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | -22.0% | - |
| FY2021 | - | - |
As of FY2022 · SEC 10-K · Updated Feb 28, 2026